Your browser doesn't support javascript.
loading
BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome.
Pooladanda, Venkatesh; Thatikonda, Sowjanya; Muvvala, Sai Priya; Devabattula, Geetanjali; Godugu, Chandraiah.
  • Pooladanda V; Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India.
  • Thatikonda S; Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India.
  • Muvvala SP; Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India.
  • Devabattula G; Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India.
  • Godugu C; Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana 500037, India. Electronic address: chandraiah@niperhyd.ac.in.
Int J Pharm ; 601: 120536, 2021 May 15.
Article en En | MEDLINE | ID: mdl-33781885
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome de Dificultad Respiratoria / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article